Innovating Works

NUTH

Desconocido
DIAMONDS: Diagnosis and Management of Febrile Illness using RNA Personalised Molecular Signature Diagnosis THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST participó en un H2020 H2020-SC1-BHC-2018-2020 Our proposal will address the challenge of bringing personalised medicine into routine use in EU healthcare systems for diagnosis and treatm...
2019-12-06 - 2025-06-30 | Financiado
ConcePTION: Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and... THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST participó en un H2020 H2020-JTI-IMI2-2017-13-two-stage ConcePTION partners have united around a shared vision that we have a societal obligation to radically and rapidly reduce uncertainty about...
2019-05-06 - 2024-12-31 | Financiado
MOBILISE-D: Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST participó en un H2020 H2020-JTI-IMI2-2017-13-two-stage Optimal treatment of the impaired mobility resulting from ageing and chronic disease is one of the 21st century's greatest challenges facing...
2019-03-22 - 2024-06-30 | Financiado
EJP RD: European Joint Programme on Rare Diseases THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST participó en un H2020 H2020-SC1-BHC-2018-2020 As recognized by the Council Recommendation 2009/C 151/02, rare diseases (RD) are a prime example of a research area that can strongly profi...
2018-12-13 - 2024-08-31 | Financiado
MCDS-Therapy: Repurposing of carbamazepine for treatment of skeletal dysplasia THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST participó en un H2020 H2020-SC1-2016-2017 Genetic skeletal diseases (GSDs) are an extremely diverse and complex group of rare genetic diseases that affect the development the skeleto...
2017-12-05 - 2024-05-31 | Financiado
MedEye: Accelerated market launch of MedEye a plug and play medication safety solution THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST participó en un H2020 H2020-FTIPilot-2016 Medication errors occur daily and form a major burden to society. Medication errors often lead to adverse drug reactions, lengthened hospita...
2016-12-11 - 2020-06-30 | Financiado
CD-MEDICS: Coeliac Disease Management Monitoring and Diagnosis using Biosensors and an Integrated Chip Syst... THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST participó en un FP7 The overall concept of the CD-MEDICS IP is to develop a technology platform for point-of-care diagnostics, capable of simultaneous genomic a...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.